Cacti

Cacti is a forward-thinking biotechnology research company dedicated to developing innovative therapies for chronic pain, inflammation, and opioid use disorder. With a focus on advancing FDA-approved, first-in-class "Nociplastigens," Cacti is committed to transforming patient care and improving lives. Located in Dallas, Texas 75077, US, Cacti’s interdisciplinary team delves into the psychological drivers of pain to create targeted and effective treatments.

The company operates with a clear mission: to bring transformative therapies to those who need them most. Cacti's research and development efforts are geared toward understanding the complexities of chronic conditions and pioneering solutions that address the root causes of pain. By combining cutting-edge science with a patient-centered approach, Cacti is making significant strides in the field of pain management.

Cacti is poised for continued growth and impact in the biotechnology sector. The company is driven by a passion for innovation and a deep commitment to improving patient outcomes. We invite the manager of Cacti to create a customized and exclusive company showcase and product listing on our platform, highlighting the groundbreaking work being done to revolutionize pain treatment and patient well-being.